NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

Clinical trial NCT03232424 · COMPLETED

Trial details

NCT number: NCT03232424
Sponsor: Hackensack Meridian Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma, Adult

Start date: 2017-07-26
Primary completion: 2022-12-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.